Therefore, our findings demonstrate that DynII plays a dual role in the regulation of ERα-based pathways in breast cancer cells (e.g., signaling and degradation) and further support the concept that endocytic proteins regulate E2:ERα-mediated physiological functions. The gene discussed is DNM2; the disease is breast cancer.